Concentra to announce Q2 2026 results on August 6

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights

Concentra Group Holdings Parent, Inc. will announce its Q2 2026 financial results on August 6, 2026, followed by a conference call on August 7. The company operates 632 occupational health centers and 411 onsite clinics, serving 54,000 patients daily.

powered bylight_fuzz_icon
45181795

*this image is generated using AI for illustrative purposes only.

Concentra Group Holdings Parent, Inc. will release its financial results for the second quarter ended June 30, 2026, on Thursday, August 6, 2026, after the market closes. The announcement will provide insights into the company's performance for the quarter.

Concentra will host a conference call to discuss the financial results on Friday, August 7, 2026, at 9 a.m. Eastern Time. The call will be accessible via a live webcast on Concentra’s investor relations website, with a replay available shortly after the event.

Participants can join the audio-only portion or the question-and-answer session using the following dial-in details:

Type Number
Toll Free 888-506-0062
International 973-528-0011
Participant Access Code 420719

Concentra is the largest provider of occupational health services in the United States by number of locations. As of March 31, 2026, the company operated 632 occupational health centers and 411 onsite health clinics across 47 states and the District of Columbia, serving approximately 54,000 patients daily on average.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

How will Concentra's Q2 2026 financial results reflect the current demand for occupational health services?

What strategic initiatives might Concentra announce to expand its footprint in the remaining states where it currently operates?

How could the company's performance impact investor sentiment toward the occupational health sector?

like16
dislike

Concentra beats Q1 estimates, raises fiscal 2026 sales guidance

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights

William Blair initiated coverage on Concentra Group Holdings Parent Inc. with an Outperform rating, citing its market leadership in occupational medicine and strong operational results. The company reported first-quarter adjusted earnings of 40 cents and sales of $569.56 million, beating consensus estimates. Concentra raised its fiscal 2026 sales guidance to $2.27 billion-$2.375 billion.

powered bylight_fuzz_icon
44482916

*this image is generated using AI for illustrative purposes only.

William Blair initiated coverage on Concentra Group Holdings Parent Inc. with an Outperform rating on Wednesday, highlighting the company's strong operational and financial results in the occupational medicine market. Analyst Jared Haase noted that Concentra shares trade at roughly 10.5 times the 2027 adjusted EBITDA estimate, above the peer group average of 10 times. Haase stated that a modest premium is warranted given the company’s unique operating model and compelling growth outlook.

Concentra reported first-quarter adjusted earnings of 40 cents, beating the consensus estimate of 35 cents. Sales jumped 13.7% to $569.56 million, surpassing the consensus of $553.49 million. The company raised its fiscal 2026 sales guidance from $2.250 billion-$2.35 billion to $2.27 billion-$2.375 billion, compared to the consensus of $2.312 billion.

Financial Performance

Concentra's first-quarter results exceeded analyst expectations, driven by strong revenue growth. The following table summarizes the key metrics:

Metric Reported Value Consensus Estimate
Adjusted Earnings 40 cents 35 cents
Sales $569.56 million $553.49 million
Fiscal 2026 Sales Guidance $2.27 billion-$2.375 billion $2.312 billion

Market Opportunity

William Blair emphasized that Concentra is the market leader in occupational medicine, a large and attractive sector. According to the National Safety Council, workplace injuries cost $181 billion in 2024, including $37 billion in direct medical expenses and $145 billion in indirect costs. Indirect costs accounted for nearly 80% of the total. Concentra’s operating model focuses on delivering quality care while shortening claims duration, which helps reduce these indirect costs.

Stock Performance

Concentra Group Holdings shares were up 3.26% at $30.72 at the time of publication on Wednesday. The stock is trading at a new 52-week high, according to Benzinga Pro data.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

How will Concentra leverage its market leadership to capture a larger share of the $181 billion workplace injury cost market?

What specific operational strategies will drive the company's growth to justify the premium valuation over peers?

Can Concentra maintain its earnings momentum amid potential economic headwinds or changes in workplace injury trends?

like15
dislike